Home/Filings/4/0000950170-25-088999
4//SEC Filing

Finegan Michael 4

Accession 0000950170-25-088999

CIK 0000884624other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 4:19 PM ET

Size

19.2 KB

Accession

0000950170-25-088999

Insider Transaction Report

Form 4
Period: 2025-06-18
Finegan Michael
VP-Bus.Dev&President-Biologics
Transactions
  • Award

    Common Stock

    2025-06-18+26,08757,391 total
Footnotes (2)
  • [F1]Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
  • [F2]Includes 29,718 previously reported deferred stock units and 1,586 shares acquired under Orthofix's Stock Purchase Plan on 4/30/2025.

Issuer

Orthofix Medical Inc.

CIK 0000884624

Entity typeother

Related Parties

1
  • filerCIK 0001391402

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:19 PM ET
Size
19.2 KB